Patrick Hopkinson | Independent HTA Expert
Independent HTA Expert
Appearances:
Day 2 @ 13:45
Panel: JCA, the first reports: Implications for Patient Access
-Key learnings and implications for Pharma
-Implications for evidence generation
-Impact on national P&R negotiation’s and patient access
Day 2 @ 13:45
Panel: JCA, the first report: Implications for Patient Access
-Impact of MFN on EMA submissions
-Is the JCA underperforming?
-The impact of the rise of global competition; i.e. US & China
last published: 27/Aug/26 16:15 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events